Abstract
Massive release of tumor necrosis factor is responsible for the potentially fatal Jarisch-Herxheimer reaction that follows antibiotic treatment of relapsing fever due to Borrelia recurrentis . We have undertaken the quantitative purification of the components of B. recurrentis that stimulate human monocytes to produce tumor necrosis factor. We show that the predominant factor inducing tumor necrosis factor is a variable lipoprotein homologous to the variable major protein of B. hermsii . We found antibodies to different forms of variable major protein in two patients with louse-borne relapsing fever. The three purified variable major proteins studied here differ in their ability to induce tumor necrosis factor production, which may partly explain the variable clinical severity of borrelial infection. These results may be of considerable relevance for the pathogenesis of Lyme disease and other forms of human borreliosis.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Johnson Jr., W.D. in Principles and Practice of Infectious Diseases, 4th ed. (eds. Mandell, G.L., Bennett, J.E. & Dolin, R.) 2141– 2143 (Churchill Livingstone, New York, 1994).
Bryceson, A.D. Clinical pathology of the Jarisch-Herxheimer reaction. J. Infect. Dis. 133, 696–704 (1976).
Luger, S.W. et al. Comparison of cefuroxime axetil and doxycycline in treatment of patients with early Lyme disease associated with erythema migrans. Antimicrob. Agents Chemother. 39, 661– 667 (1995).
Wright, D.J. Reaction following treatment of murine borreliosis and Shwartzman type reacion with borrelial sonicates. Parasite Immunol. 2, 201–221 (1980).
Negussie, Y. et al. Detection of plasma tumor necrosis factor, interleukins 6, and 8 during the Jarisch-Herxheimer Reaction of relapsing fever. J. Exp. Med. 175, 1207–1212 (1992).
Fekade, D. et al. Prevention of Jarisch-Herxheimer reactions by treatment with antibodies against tumor necrosis factor alpha. N. Engl. J. Med. 335, 311–315 (1996).
Takayama, K., Rothenberg, R.J. & Barbour, A.G. Absence of lipopolysaccharide in the Lyme disease spirochete, Borrelia burgdorferi. Infect. Immun. 55, 2311–2313 (1987).
Radolf, J.D. et al. Lipoproteins of Borrelia burgdorferi and Treponema pallidum activate cachectin/tumor necrosis factor synthesis. Analysis using a CAT reporter construct. J. Immunol. 147, 1968– 1974 (1991).
Weis, J.J., Ma, Y. & Erdile, L.F. Biological activities of native and recombinant Borrelia burgdorferi outer surface protein A: dependence on lipid modification. Infect. Immun. 62, 4632–4636 (1994).
Bouchon, B., Klein, M., Bischoff, R., Van Dorsselaer, A. & Roitsch, C. Analysis of the lipidated recombinant outer surface protein A from Borrelia burgdorferi by mass spectrometry. Anal. Biochem. 246, 52–61 (1997).
Braun, V. Covalent lipoprotein from the outer membrane of Escherichia coli. Biochim. Biophys. Acta 415, 335–377 (1975).
Fraser, C.M. et al. Genomic sequence of a Lyme disease spirochaete, Borrelia burgdorferi. Nature 390, 580–586 (1997).
Cutler, S.J. et al. Borrelia recurrentis characterization and comparison with relapsing-fever, Lyme-associated, and other Borrelia spp. Int. J. Syst. Bacteriol. 47, 958–968 (1997).
Cutler, S.J. et al. Successful in-vitro cultivation of Borrelia recurrentis. Lancet 343,–242 (1994).
de Silva, A.M.D. & Fikrig, E. Borrelia burgdorferi genes selectively expressed in ticks and mammals. Parasitol. Today 13, 267–270 (1997).
de Silva, A.M.D. & Fikrig, E. Arthropod- and host-specific gene expression by Borrelia burgdorferi. J. Clin. Invest. 99, 377–379 (1997).
Schwan, T.G., Piesman, J., Golde, W.T., Dolan, M.C. & Rosa, P.A. Induction of an outer surface protein on Borrelia burgdorferi during tick feeding. Proc. Natl. Acad. Sci. USA 92, 2909–2913 (1995).
Montgomery, R.R., Malawista, S.E., Feen, K.J. & Bockenstedt, L.K. Direct demonstration of antigenic substitution of Borrelia burgdorferi ex vivo: exploration of the paradox of the early immune response to outer surface proteins A and C in Lyme disease. J. Exp. Med. 183, 261–269 (1996).
Barbour, A.G., Tessier, S.L. & Stoenner, H.G. Variable major proteins of Borrellia hermsii. J. Exp. Med. 156, 1312–1324 (1982).
Plasterk, R.H., Simon, M.I. & Barbour, A.G. Transposition of structural genes to an expression sequence on a linear plasmid causes antigenic variation in the bacterium Borrelia hermsii. Nature 318, 257– 263 (1985).
Barbour, A.G. Antigenic variation of a relapsing fever Borrelia species. Annu. Rev. Microbiol. 44, 155–171 (1990).
Cadavid, D., Thomas, D.D., Crawley, R. & Barbour, A.G. Variability of a bacterial surface protein and disease expression in a possible mouse model of systemic Lyme borreliosis. J. Exp. Med. 179, 631–642 (1994).
Zhang, J.R., Hardham, J.M., Barbour, A.G. & Norris, S.J. Antigenic variation in Lyme disease borreliae by promiscuous recombination of VMP-like sequence cassettes. Cell 89, 275–285 (1997).
Pradines Figueres, A. & Raetz, C.R. Processing and secretion of tumor necrosis factor alpha in endotoxin-treated Mono Mac 6 cells are dependent on phorbol myristate acetate. J. Biol. Chem. 267, 23261–23268 (1992).
Allan, R.J., Rowe, A. & Kwiatkowski, D. Plasmodium falciparum varies in its ability to induce tumor necrosis factor. Infect. Immun. 61, 4772–4776 (1993).
Matsudaira, P. in A Practical Guide to Protein Purification for Microsequencing (Academic Press, London, 1993).
Barbour, A.G. & Garon, C.F. Linear plasmids of the bacterium Borrelia burgdorferi have covalently closed ends. Science 237, 409–411 (1987).
Acknowledgements
We thank L. Barber for peptide sequencing. This work was funded by the Medical Research Council, UK.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Vidal, V., Scragg, I., Cutler, S. et al. Variable major lipoprotein is a principal TNF-inducing factor of louse-borne relapsing fever. Nat Med 4, 1416–1420 (1998). https://doi.org/10.1038/4007
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/4007
This article is cited by
-
Characterisation of silent and active genes for a variable large protein of Borrelia recurrentis
BMC Infectious Diseases (2002)